GlobeNewswire

Leading AI-Powered Ecommerce Personalization Platform, Nosto, Launches New Content Personalization, Segmentation Tools and Insights

Del

NEW YORK and HELSINKI, Finland, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Nosto, a leader in ecommerce personalization and artificial intelligence (AI) tools for retail, today launched its new platform enhancements, including Content Personalization, Segmentation and Insights. These new offerings allow ecommerce retailers to deliver completely unique and highly targeted shopping experiences to different types of customers, deepening the customer’s relationship with the brand across the retail website, emails, pop-ups, Facebook and Instagram ads and more.

The company’s innovative retail personalization solutions have fueled a three-year growth rate of 260 percent in North America driven by deep relationships with 2,500 of the world’s fastest growing brands. Nosto has also driven a gross merchandise volume (GMV) of more than $10 billion through its customer stores, and is averaging a 22 percent increase year over year GMV for retail customers, significantly higher than the average of 14 percent for ecommerce retailers.

“When we first launched Nosto, our focus was on delivering AI-powered, personalized recommendations for products across an online store in real-time. Today, we’re expanding these capabilities by leveraging our vast network of retail data to deliver even more robust experiences -- a fully personalized shopping experience with web content perfectly fitting the customer across any digital channel,” said Jim Lofgren, CEO of Nosto.  “We’re energized by what we have been seeing during the beta period of these new products -- increased sales and deeper brand relationships with retailers.”

Today’s new platform enhancements include:

  • Content Personalization: Nosto’s Content Personalization platform goes beyond product recommendations, enabling ecommerce retailers to deliver completely different shopping experiences to different types of customers through real-time actionability. By creating dynamic, instant personalization based on different insights and personas, retailers are able to offer a fully customized and relevant customer journey for every individual who interacts with the brand.
     
  • Segmentation: Nosto’s new AI-powered Segmentation leverages real-time behavioral and transactional data to identify customer positions in the shopping funnel and significantly improves targeting by immediately updating their interactions. By tracking their behavior in real-time and automatically updating their moment-by-moment experience, Nosto is able to deliver the most relevant experience at every point in the shopping journey.
     
  • Insights: To best leverage the real-time data that powers AI, Nosto has developed an Insights platform so retailers can access all of the valuable data collected from their site to get a deeper understanding of every shopper that comes to their store and how they are interacting with their products. These insights provide retailers with deeper and more complex data which can help identify new opportunities for growth.

“Nosto’s goal has been to deliver an expanded platform to transform the way people experience online retail by making those experiences far more relevant and personal. 
In order to deliver a truly personalized brand experience, retailers need to go beyond products and look at the brand experience as a whole,” said Lofgren. “Today, we’re delivering tools that enable our retailers to leverage our proprietary AI and machine learning algorithms, which now can be used to create memorable brand experiences at scale, ultimately driving more sales.”

About Nosto
Nosto is the fastest growing ecommerce personalization and retail AI platform in the world. Supporting more than 2,500 retail brands in more than 100 countries, Nosto has fueled over 25 billion personalized experiences and delivered a gross merchandise volume (GMV) of more than $10 billion through its customer stores. Nosto’s end-to-end personalization platform provides deep customer insights that drive real-time personalized shopping experiences across any touch point and any device. Through its patented technology, proprietary machine learning algorithms, vast network of ecommerce data and dedicated customer success team, Nosto supports its retailers from its offices in New York, Los Angeles, London, Berlin, Paris, Stockholm and Helsinki. More information can be found at http://www.nosto.com/.

Media Contact:
Heidi Davidson
Galvanize Worldwide for Nosto
Heidi@Galvanizeworldwide.com
(914) 441-6862

Om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg saker fra GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra GlobeNewswire

ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ADCT-601 in Advanced Solid Tumors16.1.2019 07:00Pressemelding

Pyrrolobenzodiazepine-based antibody drug conjugate targets AXL, a receptor tyrosine kinase highly expressed in solid tumors LAUSANNE, Switzerland, Jan. 16, 2019 (GLOBE NEWSWIRE) -- ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of proprietary antibody drug conjugates (ADCs), today announced that the first patient has been dosed in its Phase I clinical trial evaluating the safety, tolerability, pharmacokinetics and anti-tumor activity of ADCT-601 in patients with selected solid tumors that are locally advanced or metastatic. ADCT-601 is an ADC composed of a humanized monoclonal antibody against human AXL, conjugated using GlycoConnect™ site specific conjugation technology to a pyrrolobenzodiazepine (PBD) dimer toxin. In preclinical studies, ADCT-601 demonstrated potent and specific in vitro and in vivo anti-tumor activity in multiple cancer-derived models with different levels of AXL expression, and was stable and well tolerated

GSA Europe’s Managing Director Elected Co-lead of CEN’s TC456 Committee15.1.2019 21:12Pressemelding

SAN GWANN, Malta, Jan. 15, 2019 (GLOBE NEWSWIRE) -- GSA Europe’s Managing Director Mark Pace has been elected by the Comité Européen de Normalisation (CEN) to lead the creation of a European Union online gaming reporting standard. CEN has established Technical Committee 456 to create this standard in support of online gambling supervision. GSA Europe joined Technical Committee 456 as a Liaison Organization in 2017. The Technical Committee’s mandate from the European Commission is directly aligned with work that GSA Europe has already started, namely, to create a single standard set of data elements and single standard way in which data is provided by online gambling providers to EU Member State regulatory authorities. In addition to joining and now leading the Technical Committee’s work, GSA Europe also donated their draft Regulatory Data Set and Regulatory Reporting Interface to CEN seeking to help jump-start the Committee’s work. “Joining CEN’s TC456 as a Liaison Organization, and no

Orion Biotechnology Reports Positive Results for Colorectal Cancer in Preclinical Study15.1.2019 15:00Pressemelding

OTTAWA, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced preclinical data produced in collaboration with Charles River Laboratories, evaluating the efficacy of OB-002O (5P12-RANTES) in colorectal cancer. BALB/c mice were inoculated subcutaneously with the CT-26 colorectal cancer cell line. Three days after inoculation intraperitoneal treatment was started with OB-002O, a murine anti-PD-1 antibody, OB-002 + anti-PD-1, or saline placebo. Treatment was given daily or every third day. Treatment with OB-0020 alone led to statistically significant delayed tumor growth at multiple time-points. An even more profound effect on the decrease in mean tumor volume was observed in combination cohort where animals received both, OB-0020 and the anti-PD-1 antibody (p>0.05). “There is growing awareness of the role of CCR5 antagonism as an important component of cancer immunotherapy. OB-002O is an extremely potent CCR5 antagonist

Credit Suisse Partners with CGAP on Digital Finance to Catalyze Delivery of Energy, Water and other Services to Low Income People15.1.2019 14:08Pressemelding

Washington/Zurich, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Credit Suisse, one of the world's leading financial services providers, is partnering with the Consultative Group to Assist the Poor (CGAP) to support its work in building inclusive and responsible financial systems that help people move out of poverty, protect their economic gains and advance the broader global development agenda. CGAP is a global partnership of more than 30 leading development agencies, private foundations and national governments committed to financial inclusion as a means toward expanding opportunities for poor people. Through their engagement, CGAP and Credit Suisse will capitalize upon and leverage each other’s knowledge to further financial inclusion and its contribution toward achieving the United Nations’ Sustainable Development Goals (SDGs). Among the projects that align well with Credit Suisse’s expertise are CGAP’s work on sustainable business models that use digital finance technologies to lower the cost

TrueCommerce Recognized as a Leader in IDC MarketScape for Worldwide Multi-Enterprise Supply Chain Commerce Network15.1.2019 14:00Pressemelding

-- “The vendor offers a true partnership for their customers and has become an extension of their internal staff and resources to manage their supply chains,” says the report -- PITTSBURGH, Jan. 15, 2019 (GLOBE NEWSWIRE) -- TrueCommerce, a global provider of trading partner connectivity, integration and unified commerce solutions , has announced today it was positioned in the Leaders category of the IDC MarketScape for Worldwide Multi-Enterprise Supply Chain Commerce Network report. The research states that TrueCommerce offers a broad set of supply chain applications that extend far beyond traditional data transportation. “Our investments into the cutting-edge unified commerce technology and customer care allowed the company to make this qualitative leap, and we are proud to be recognized by such a reputable global research firm as IDC,” said TrueCommerce president Ross Elliott. “The report advises companies to engage with a network vendor that is at least thinking about what tomorrow

UnionBank Launches First Fully Digital Branch in the Philippines15.1.2019 13:30Pressemelding

Appian Cloud Platform Enables Low-Code Rapid Application Development for Powerful Process Automation RESTON, Va. and SYDNEY, Australia , Jan. 15, 2019 (GLOBE NEWSWIRE) -- Appian (NASDAQ: APPN) announces that UnionBank of the Philippines used the Appian Platform to launch its first fully digital branch. The branch, called The Ark, completely transforms the customer experience, making that experience entirely digital, including internet-connected self-service kiosks and virtual reality boxes. Unlike traditional bank branches, The Ark has done away with rows of tellers and long queues, and gone completely paperless. Customers now go to one of the self-service iPad stands stationed around the bank, where they can type in their request, significantly reducing time previously spent waiting in queues for service. “The Ark is an award-winning digital branch that provides a modern experience for our clients within a traditional brick and mortar store,” said Anna Maria Aboitiz Delgado, Head for